The company announced that the US FDA has expanded the approved use of its oral antiviral drug Mavyret, developed in ...

The US coffee company shared on its Weixin account that the move aims to make a wide range of drinks, including non-coffee ...

According to CEO Julie Sweet, the company’s generative AI-related revenue has jumped to $2.6 billion over the past six months ...

This updated outlook differs from the company’s December 2024 announcement, when it aimed to open 10 to 15 stores annually.

According to Bloomberg analyst Eric Balchunas, IBIT, the leading option among the 12 Bitcoin ETFs currently on the market, ...

Although the latest dividend remained unchanged from the previous one, the company has maintained a 33-year track record of ...

T. Rowe Price Group, Inc. (NASDAQ:TROW) is also known for its reliable dividend payments. It has been rewarding shareholders ...